Furthermore, tumour-infiltrating CTLs in cervical carcinomas lack expression of the activating receptor CD94/NKG2C, but, in contrast, do express the inhibiting receptor CD94/NKG2A [23,38]. The gene discussed is KLRC1; the disease is neoplasm.